{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:31:44Z","timestamp":1792621904733,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,7,31]],"date-time":"2011-07-31T00:00:00Z","timestamp":1312070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s10096-011-1360-5","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T22:22:34Z","timestamp":1311978154000},"page":"695-701","source":"Crossref","is-referenced-by-count":147,"title":["Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates"],"prefix":"10.1007","volume":"31","author":[{"given":"G.","family":"Samonis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Maraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. E.","family":"Karageorgopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. K.","family":"Vouloumanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Falagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,31]]},"reference":[{"key":"1360_CR1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/138945009789108846","volume":"10","author":"R Maviglia","year":"2009","unstructured":"Maviglia R, Nestorini R, Pennisi M (2009) Role of old antibiotics in multidrug resistant bacterial infections. Curr Drug Targets 10:895\u2013905","journal-title":"Curr Drug Targets"},{"key":"1360_CR2","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.257.5073.1064","volume":"257","author":"HC Neu","year":"1992","unstructured":"Neu HC (1992) The crisis in antibiotic resistance. Science 257:1064\u20131073","journal-title":"Science"},{"key":"1360_CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10096-009-0833-2","volume":"29","author":"M Popovic","year":"2010","unstructured":"Popovic M, Steinort D, Pillai S, Joukhadar C (2010) Fosfomycin: an old, new friend? Eur J Clin Microbiol Infect Dis 29:127\u2013142","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1360_CR4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijantimicag.2009.08.013","volume":"34","author":"N Roussos","year":"2009","unstructured":"Roussos N, Karageorgopoulos DE, Samonis G, Falagas ME (2009) Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int J Antimicrob Agents 34:506\u2013515","journal-title":"Int J Antimicrob Agents"},{"key":"1360_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","volume":"10","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE (2010) Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10:43\u201350","journal-title":"Lancet Infect Dis"},{"key":"1360_CR6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijantimicag.2009.10.019","volume":"35","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Mavromanolakis E, Samonis G (2010) Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents 35:240\u2013243","journal-title":"Int J Antimicrob Agents"},{"key":"1360_CR7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/527442","volume":"46","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Giannopoulou KP, Kokolakis GN, Rafailidis PI (2008) Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis 46:1069\u20131077","journal-title":"Clin Infect Dis"},{"key":"1360_CR8","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","volume":"47","author":"AI Nilsson","year":"2003","unstructured":"Nilsson AI, Berg OG, Aspevall O, Kahlmeter G, Andersson DI (2003) Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother 47:2850\u20132858","journal-title":"Antimicrob Agents Chemother"},{"key":"1360_CR9","doi-asserted-by":"crossref","first-page":"e10193","DOI":"10.1371\/journal.pone.0010193","volume":"5","author":"A Rodr\u00edguez-Rojas","year":"2010","unstructured":"Rodr\u00edguez-Rojas A, Maci\u00e1 MD, Couce A, G\u00f3mez C, Casta\u00f1eda-Garc\u00eda A, Oliver A, Bl\u00e1zquez J (2010) Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections. PLoS One 5:e10193","journal-title":"PLoS One"},{"key":"1360_CR10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1086\/528867","volume":"46","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Karageorgopoulos DE (2008) Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 46:1121\u20131122","journal-title":"Clin Infect Dis"},{"key":"1360_CR11","first-page":"649","volume-title":"Manual of clinical microbiology","author":"JJ Farmer 3rd","year":"2007","unstructured":"Farmer JJ 3rd, Boatwright KD, Janda JM (2007) Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology. ASM Press, Washington, DC, pp 649\u2013669"},{"key":"1360_CR12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA (2005) Extended-spectrum \u03b2-lactamases: a clinical update. Clin Microbiol Rev 18:657\u2013686","journal-title":"Clin Microbiol Rev"},{"key":"1360_CR13","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/JCM.00015-07","volume":"45","author":"KF Anderson","year":"2007","unstructured":"Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, Carey RB, Thompson A, Stocker S, Limbago B, Patel JB (2007) Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 45:2723\u20132725","journal-title":"J Clin Microbiol"},{"key":"1360_CR14","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JCM.41.10.4623-4629.2003","volume":"41","author":"K Lee","year":"2003","unstructured":"Lee K, Lim Y, Yong D, Yum J, Chong Y (2003) Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-\u03b2-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41:4623\u20134629","journal-title":"J Clin Microbiol"},{"key":"1360_CR15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","volume":"20","author":"AM Queenan","year":"2007","unstructured":"Queenan AM, Bush K (2007) Carbapenemases: the versatile \u03b2-lactamases. Clin Microbiol Rev 20:440\u2013458","journal-title":"Clin Microbiol Rev"},{"key":"1360_CR16","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing; Twentienth informational supplement. CLSI Document M100-S20. CLSI, Wayne, PA, USA"},{"key":"1360_CR17","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","volume":"40","author":"RL White","year":"1996","unstructured":"White RL, Burgess DS, Manduru M, Bosso JA (1996) Comparison of three different in vitro methods of detecting synergy: time\u2013kill, checkerboard, and E test. Antimicrob Agents Chemother 40:1914\u20131918","journal-title":"Antimicrob Agents Chemother"},{"key":"1360_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1","journal-title":"J Antimicrob Chemother"},{"key":"1360_CR19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00228-010-0794-5","volume":"66","author":"AC Kastoris","year":"2010","unstructured":"Kastoris AC, Rafailidis PI, Vouloumanou EK, Gkegkes ID, Falagas ME (2010) Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. Eur J Clin Pharmacol 66:359\u2013368","journal-title":"Eur J Clin Pharmacol"},{"key":"1360_CR20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jac\/dkp282","volume":"64","author":"DL MacLeod","year":"2009","unstructured":"MacLeod DL, Barker LM, Sutherland JL, Moss SC, Gurgel JL, Kenney TF, Burns JL, Baker WR (2009) Antibacterial activities of a fosfomycin\/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. J Antimicrob Chemother 64:829\u2013836","journal-title":"J Antimicrob Chemother"},{"key":"1360_CR21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF01709477","volume":"16","author":"F Tessier","year":"1997","unstructured":"Tessier F, Quentin C (1997) In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 16:159\u2013162","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"1360_CR22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000222031","volume":"23","author":"R Daza","year":"1977","unstructured":"Daza R, Moreno-L\u00f3pez M, D\u00e1maso D (1977) Interactions of fosfomycin with other antibiotics. Chemotherapy 23(Suppl 1):86\u201392","journal-title":"Chemotherapy"},{"key":"1360_CR23","first-page":"671","volume":"36","author":"Y Buisson","year":"1988","unstructured":"Buisson Y, Bercion R, Maucl\u00e8re P, Hugard L, Schill H (1988) Preliminary study of the antagonistic effects between fosfomycin and beta-lactams on Pseudomonas aeruginosa observed on the antibiogram. Pathol Biol (Paris) 36:671\u2013674","journal-title":"Pathol Biol (Paris)"},{"key":"1360_CR24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/clinids\/4.2.282","volume":"4","author":"GM Eliopoulos","year":"1982","unstructured":"Eliopoulos GM, Moellering RC Jr (1982) Antibiotic synergism and antimicrobial combinations in clinical infections. Rev Infect Dis 4:282\u2013293","journal-title":"Rev Infect Dis"},{"key":"1360_CR25","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0969-2126(96)00153-0","volume":"4","author":"T Skarzynski","year":"1996","unstructured":"Skarzynski T, Mistry A, Wonacott A, Hutchinson SE, Kelly VA, Duncan K (1996) Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin. Structure 4:1465\u20131474","journal-title":"Structure"},{"key":"1360_CR26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jac\/27.3.263","volume":"27","author":"A Grossato","year":"1991","unstructured":"Grossato A, Sartori R, Fontana R (1991) Effect of non-beta-lactam antibiotics on penicillin-binding protein synthesis of Enterococcus hirae ATCC 9790. J Antimicrob Chemother 27:263\u2013271","journal-title":"J Antimicrob Chemother"},{"key":"1360_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02489184","volume":"3","author":"K Totsuka","year":"1997","unstructured":"Totsuka K, Uchiyama T, Shimizu K, Kanno Y, Takata T, Yoshida T (1997) In vitro combined effects of fosfomycin and \u03b2-lactam antibiotics against penicillin-resistant Streptococcus pneumoniae. J Infect Chemother 3:49\u201354","journal-title":"J Infect Chemother"},{"key":"1360_CR28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1469-0691.2009.02921.x","volume":"16","author":"A Michalopoulos","year":"2010","unstructured":"Michalopoulos A, Virtzili S, Rafailidis P, Chalevelakis G, Damala M, Falagas ME (2010) Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation. Clin Microbiol Infect 16:184\u2013186","journal-title":"Clin Microbiol Infect"},{"key":"1360_CR29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","volume":"9","author":"P Nordmann","year":"2009","unstructured":"Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228\u2013236","journal-title":"Lancet Infect Dis"},{"key":"1360_CR30","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/AAC.00782-08","volume":"53","author":"GL Daikos","year":"2009","unstructured":"Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, Georgousi K, Tzouvelekis LS, Tassios PT, Bamia C, Petrikkos G (2009) Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 53:1868\u20131873","journal-title":"Antimicrob Agents Chemother"},{"key":"1360_CR31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.26.5.789","volume":"26","author":"K Takahashi","year":"1984","unstructured":"Takahashi K, Kanno H (1984) Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 26:789\u2013791","journal-title":"Antimicrob Agents Chemother"},{"key":"1360_CR32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0732-8893(00)00163-2","volume":"38","author":"CR Bonapace","year":"2000","unstructured":"Bonapace CR, White RL, Friedrich LV, Bosso JA (2000) Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time\u2013kill, and checkerboard methods. Diagn Microbiol Infect Dis 38:43\u201350","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1360_CR33","first-page":"263","volume":"27","author":"G Bonaventura Di","year":"2004","unstructured":"Di Bonaventura G, Picciani C, Spedicato I, Piccolomini R (2004) E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach. New Microbiol 27:263\u2013272","journal-title":"New Microbiol"},{"key":"1360_CR34","doi-asserted-by":"crossref","unstructured":"Giakoupi P, Maltezou H, Polemis M, Pappa O, Saroglou G, Vatopoulos A (2009) KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 14.","DOI":"10.2807\/ese.14.21.19218-en"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1360-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1360-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1360-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T11:49:20Z","timestamp":1560426560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1360-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,31]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1360-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,31]]}}}